Anne Kiil Berthelsen

Medicine & Life Sciences

1. Radiotherapy 100%
2. Positron Emission Tomography Computed Tomography 73%
3. Positron-Emission Tomography 56%
4. Fluorodeoxyglucose F18 54%
5. Hodgkin Disease 53%
6. 64Cu-DOTATATE 49%
7. Neoplasms 36%
8. Lymphoma 28%
9. Pediatrics 24%
10. Head and Neck Neoplasms 24%
11. Recurrence 22%
12. Radiation Oncology 22%
13. Tomography 19%
14. Urokinase Plasminogen Activator Receptors 18%
15. Therapeutics 18%
16. Intensity-Modulated Radiotherapy 17%
17. Deep Learning 16%
18. Lung Neoplasms 16%
19. Respiration 16%
20. Medulloblastoma 16%
21. Edotreotide 15%
22. Neuroendocrine Tumors 15%
23. 1,4,7-triazacyclononane-N,N',N''-triacetic acid 15%
24. Squamous Cell Carcinoma of Head and Neck 14%
25. Radiation 14%
26. Conformal Radiotherapy 13%
27. Neoplasm Metastasis 13%
28. Image-Guided Radiotherapy 13%
29. Neoplasm Staging 13%
30. Guidelines 13%
31. Proton Therapy 12%
32. Uterine Cervical Neoplasms 12%
33. Ovarian Neoplasms 11%
34. Progression-Free Survival 11%
35. Uncertainty 11%
36. Survival 11%
37. Radiosurgery 11%
38. Photons 10%
39. Lymph Nodes 10%
40. Observer Variation 10%
41. Drug Therapy 10%
42. Lung 9%
43. Prospective Studies 9%
44. Neck 9%
45. Breast Neoplasms 9%
46. Magnetic Resonance Imaging 9%
47. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 9%
48. Artifacts 9%
49. Organs at Risk 9%
50. Endometrial Neoplasms 8%